Featured Research

from universities, journals, and other organizations

Towards Malaria 'Vaccine': Discovery Opens The Door To Malaria-prevention Therapies

Date:
August 23, 2009
Source:
McGill University Health Centre
Summary:
Malaria kills anywhere from one to three million people around the world annually and affects the lives of up to 500 million more. Yet until now, scientists did not fully understand exactly how the process that caused the disease's severe hallmark fevers began. Now researchers believe they may have solved this mystery.

Malaria kills anywhere from one to three million people around the world annually and affects the lives of up to 500 million more. Yet until now, scientists did not fully understand exactly how the process that caused the disease's severe hallmark fevers began.

Related Articles


A team led by Dr. Martin Olivier from the Research Institute of the McGill University Health Centre (RI-MUHC) and McGill University in Montreal has solved this mystery, and may have blazed a trail towards the development of vaccine-like treatments to limit the severity of the devastating parasitic ailment. The results of their study will be published August 21 in the journal PLoS Pathogens.

Malaria is a mosquito-borne infectious disease spread by parasites from the Plasmodium family. Inside the human body, the malaria parasite infects red blood cells where it survives and reproduces by feeding on the cells' contents. Eventually the cells burst, releasing the parasites and also a waste byproduct of their reproductive process: hemozoin.

Researchers at the RI-MUHC and McGill University, discovered that hemozoin, a crystal-like substance may be the missing link that explains why malaria leads to devastating inflammation and fever.

"Our results describe the mechanism by which the hemozoin activates the immune system, resulting in the production of inflammation mediators and in the high fever that we witness in malaria patients," said study first-author Dr. Marina Tiemi Shio of the RI-MUHC.

Hemozoin is first ingested by 'cleaning' cells called macrophages, explained the researcher which leads to a chain reaction ending in the activation of the inflammasome: an important structure inside immune cells which lead to inflammation. Activation of the inflammasome produces the body's fever mediator, interleukin beta (IL-beta).

"Our work is a milestone in that it is the first study that reveals the enzymes that act as intermediary between the hemozoin and inflammasome," explained Dr. Olivier. "Now our picture of the process that goes from infection to fever is more or less complete."

"On the other hand we also proved that malaria is too complex to be narrowed down to one single mechanism," he continued. "In the absence of either IL-beta or a functional inflammsaome, the development of the disease is delayed but not completely stopped. Although the discovery of this relationship is important, there are other mechanisms at work."

The mechanisms that go from the activation of the inflammasome to the onset of the malaria symptoms were already familiar to scientists, but until now the beginning of the process was unknown.

"These results prove the primary role hemozoin plays in the development of malaria, and designates it as a favoured choice for future innovative treatments," added Dr. Olivier.

The researchers believe it will be possible to familiarize the immune system to small quantities of hemozoin and diminish the inflammatory response in the event of infection, according to a principle similar to that of vaccines.

The study was funded by a grant from the Canadian Institutes of Health Research (CIHR).

The article was co-authored by Dr. Marina Tiemi Sho, Dr. Myriam Savaria, Dr. Marie-Josée Bellemare, from the Research Institute of the McGill University Health Centre and McGill University, Dr. D. Scott Bohle from McGill University and Dr. Martin Olivier from the RI MUHC and McGill University and, by Dr. Stephanie C. Eisenbarth, and Dr. Richard A. Flavell from Yale University, by Dr. Adrien F. Vinet and Dr. Albert Descoteaux of the l'Institut Armand-Frappier, by Dr. Kenneth W. Harder of the University of British Columbia, and by Dr. Fayyaz S. Sutterwala from the University of Iowa.


Story Source:

The above story is based on materials provided by McGill University Health Centre. Note: Materials may be edited for content and length.


Journal Reference:

  1. Tiemi Shio M, Eisenbarth SC, Savaria M, Vinet AF, Bellemare M-J, et al. Malarial Hemozoin Activates the NLRP3 Inflammasome through Lyn and Syk Kinases. PLoS Pathogens, 2009; 5 (8): e1000559 DOI: 10.1371/journal.ppat.1000559

Cite This Page:

McGill University Health Centre. "Towards Malaria 'Vaccine': Discovery Opens The Door To Malaria-prevention Therapies." ScienceDaily. ScienceDaily, 23 August 2009. <www.sciencedaily.com/releases/2009/08/090820204458.htm>.
McGill University Health Centre. (2009, August 23). Towards Malaria 'Vaccine': Discovery Opens The Door To Malaria-prevention Therapies. ScienceDaily. Retrieved November 1, 2014 from www.sciencedaily.com/releases/2009/08/090820204458.htm
McGill University Health Centre. "Towards Malaria 'Vaccine': Discovery Opens The Door To Malaria-prevention Therapies." ScienceDaily. www.sciencedaily.com/releases/2009/08/090820204458.htm (accessed November 1, 2014).

Share This



More Health & Medicine News

Saturday, November 1, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Melafind: Spotting Melanoma Without a Biopsy

Melafind: Spotting Melanoma Without a Biopsy

Ivanhoe (Oct. 31, 2014) — The MelaFind device is a pain-free way to check suspicious moles for melanoma, without the need for a biopsy. Video provided by Ivanhoe
Powered by NewsLook.com
Battling Multiple Myeloma

Battling Multiple Myeloma

Ivanhoe (Oct. 31, 2014) — The answer isn’t always found in new drugs – repurposing an ‘old’ drug that could mean better multiple myeloma treatment, and hope. Video provided by Ivanhoe
Powered by NewsLook.com
Chronic Inflammation and Prostate Cancer

Chronic Inflammation and Prostate Cancer

Ivanhoe (Oct. 31, 2014) — New information that is linking chronic inflammation in the prostate and prostate cancer, which may help doctors and patients prevent cancer in the future. Video provided by Ivanhoe
Powered by NewsLook.com
Sickle Cell: Stopping Kids’ Silent Strokes

Sickle Cell: Stopping Kids’ Silent Strokes

Ivanhoe (Oct. 31, 2014) — Blood transfusions are proving crucial to young sickle cell patients by helping prevent strokes, even when there is no outward sign of brain injury. Video provided by Ivanhoe
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
 
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:  

Breaking News:

Strange & Offbeat Stories

 

Health & Medicine

Mind & Brain

Living & Well

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:  

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile iPhone Android Web
Follow Facebook Twitter Google+
Subscribe RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins